Meningococcal vaccine group B conjugate (Baxter International)

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameMeningococcal vaccine group B conjugate (Baxter International)

Drug Alias NameNeisVac-B

ClassificationVaccines > Biological material > Bacterial vaccineVaccines > Application > Therapeutic vaccineVaccines > Development/production technology > Conjugated vaccine

Mechanisms of ActionImmunostimulants

TargetsNot applicable

Therapy Area/IndicationsMeningitis

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusPending (Phase 2 Clinical)

Highest Status in ChinaN/A

Originator CompaniesBaxter International Inc

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesBaxter International Inc

Active IndicationsN/A

Inactive IndicationsMeningitis

Other Information

ATC CodeN/A